Rituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity

• Váldodahkkit: Robin J. Svensson (Dahkki), Qing Xi Ooi (Dahkki), Lena E. Friberg (Dahkki), Narendra Maharaj (Dahkki), Pramod Kumar Reddy (Dahkki), Luis López‐Lázaro (Dahkki), Emma Hansson (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2023-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Dr. Reddy's Laboratories rituximab (DRL_RI; Dr. Reddy's Laboratories SA, Basel, Switzerland) is under development as a rituximab biosimilar. Study RI‐01‐002 (Clinical Trials Registry ‐ India/2012/11/003129), comparing DRL_RI to the reference medicinal product (RMP) MabThera® (Roch...